Perspective Therapeutics, Inc.
CATX
$3.90
-$0.03-0.76%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -103.12M | -105.80M | -94.95M | -73.47M | -67.58M |
| Total Depreciation and Amortization | 3.24M | 2.94M | 2.84M | 2.10M | 1.73M |
| Total Amortization of Deferred Charges | 7.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.71M | 28.81M | 28.68M | 26.97M | 26.11M |
| Change in Net Operating Assets | 1.68M | -10.40M | -1.35M | -435.00K | 30.34M |
| Cash from Operations | -82.48M | -84.43M | -64.78M | -53.72M | -18.29M |
| Capital Expenditure | -12.75M | -22.29M | -50.01M | -48.98M | -53.40M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.98M | -103.96M | -119.97M | -125.26M | -162.57M |
| Cash from Investing | 41.23M | -125.91M | -169.64M | -177.20M | -218.93M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -52.00K | -51.00K | -54.00K | -41.00K | -40.00K |
| Issuance of Common Stock | 10.36M | 10.71M | 11.13M | 10.99M | 167.34M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.31M | 10.66M | 11.08M | 133.03M | 289.39M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.95M | -199.68M | -223.34M | -97.89M | 52.16M |